Latest Commercialisation News

Invion Limited has secured a pivotal FDA Orphan Drug Designation for its lead cancer drug INV043, bolstered its balance sheet with nearly $1.8 million in new funding, and progressed clinical trials targeting skin and anogenital cancers.

Livium Ltd has completed its strategic pivot to focus on recycling clean energy waste, reporting solid Q1 FY26 results and securing a significant capital raise to fuel expansion into battery, solar panel, and rare-earth element recycling.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.

Pathkey.AI reports strong validation of its TrialKey AI platform’s predictive accuracy and announces key leadership changes as it advances toward commercial scale.

Aspermont Limited reports a milestone $11.2 million annual recurring revenue with its new Mining-IQ platform gaining traction through a landmark Rio Tinto contract. The company also strengthens its balance sheet with a $2.8 million capital raise, setting the stage for accelerated growth.

Sarytogan Graphite Limited reports strong progress in graphite and copper exploration, securing key DFS contracts and a $3.6 million placement to advance its flagship projects.

Holista Colltech reported improved cash flow management and robust growth in its dietary supplements division for 3QFY25, while navigating ongoing legal challenges with ProImmune.

BPH Energy’s September quarter report highlights pivotal developments across its investees, from a critical judicial review in offshore petroleum to breakthroughs in AI medical devices and clean hydrogen production.

Titomic Limited has launched a major European manufacturing hub and a UK subsidiary, secured a $50 million capital raise, and forged strategic partnerships to advance its cold spray additive manufacturing technology.

Nanollose Limited has made significant progress in microbial cellulose production, enabling direct integration into lyocell fibre manufacturing, while securing $750,000 in funding through option exercises by Fiftyone Capital.

Elixir Energy reports promising gas pay results at Diona-1 and secures a premium drilling rig for the upcoming Lorelle-3 appraisal well, positioning itself for a pivotal phase in the Taroom Trough.